12 March 2019
Diabefarm MR in the new dosage
In the first quarter of 2019, Pharmacor Production starts producing Diabepharm MR with a dosage of 60 mg — prolonged-release tablets No. 30. Since 2007, the company has been producing Gliclazide tablets with INN (grouped chemical name) in dosages of 30 mg and 80 mg.
Diabepharm MR refers to the group of hypoglycemic agents for oral use of the II generation sulfonylurea group, used in type 2 diabetes mellitus.